We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Drugmaker Akorn to Pay $7.9 Million Medicare Fine
Generic Drugmaker Akorn to Pay $7.9 Million Medicare Fine
Resolving allegations that it violated the False Claims Act, generic drugmaker Akorn has entered into a settlement to pay $7.9 million for causing Medicare to be billed for three over-the-counter (OTC) drugs that were no longer eligible for Medicare coverage.